HKD6.50
0.91% yesterday
Hong Kong, Sep 23, 10:08 am CET
ISIN
BMG0171K1018
Symbol
0241
Index

Alibaba Health Information Technology Target price 2025 - Analyst rating & recommendation

Alibaba Health Information Technology Classifications & Recommendation:

Buy
57%
Hold
33%
Sell
10%

Alibaba Health Information Technology Price Target

Target Price HKD5.61
Price HKD6.50
Deviation
Number of Estimates 19
19 Analysts have issued a price target Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology target price is HKD5.61. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 12 Analysts recommend Alibaba Health Information Technology to buy, 7 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alibaba Health Information Technology stock has an average upside potential 2026 of . Most analysts recommend the Alibaba Health Information Technology stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Billion HKD 33.45 37.17
13.22% 11.23%
EBITDA Margin 5.41% 6.36%
87.65% 17.59%
Net Margin 4.68% 6.79%
43.21% 45.04%

20 Analysts have issued a sales forecast Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology sales estimate is

HKD37.2b
Unlock
. This is
11.23% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD42.3b 26.51%
Unlock
, the lowest is
HKD32.8b 1.88%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HKD33.5b 13.22%
2026
HKD37.2b 11.23%
Unlock
2027
HKD41.0b 10.43%
Unlock
2028
HKD44.3b 8.03%
Unlock
2029
HKD49.0b 10.55%
Unlock
2030
HKD56.7b 15.71%
Unlock
2031
HKD62.0b 9.33%
Unlock
2032
HKD67.7b 9.13%
Unlock

15 Analysts have issued an Alibaba Health Information Technology EBITDA forecast 2026. The average Alibaba Health Information Technology EBITDA estimate is

HKD2.4b
Unlock
. This is
54.48% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD3.0b 93.41%
Unlock
, the lowest is
HKD1.8b 19.89%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 HKD1.8b 112.45%
2026
HKD2.4b 30.88%
Unlock
2027
HKD2.9b 24.24%
Unlock
2028
HKD3.6b 22.93%
Unlock
2029
HKD4.2b 15.84%
Unlock
2030
HKD3.8b 8.14%
Unlock
2031
HKD4.3b 12.36%
Unlock
2032
HKD4.8b 11.48%
Unlock

EBITDA Margin

2025 5.41% 87.65%
2026
6.36% 17.59%
Unlock
2027
7.16% 12.58%
Unlock
2028
8.15% 13.83%
Unlock
2029
8.54% 4.79%
Unlock
2030
6.78% 20.61%
Unlock
2031
6.96% 2.65%
Unlock
2032
7.11% 2.16%
Unlock

19 Alibaba Health Information Technology Analysts have issued a net profit forecast 2026. The average Alibaba Health Information Technology net profit estimate is

HKD2.5b
Unlock
. This is
61.27% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD3.0b 94.22%
Unlock
, the lowest is
HKD1.8b 15.35%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HKD1.6b 62.14%
2026
HKD2.5b 61.27%
Unlock
2027
HKD3.0b 20.07%
Unlock
2028
HKD3.5b 15.73%
Unlock
2029
HKD4.5b 27.01%
Unlock
2030
HKD4.7b 6.45%
Unlock
2031
HKD5.4b 14.81%
Unlock
2032
HKD6.1b 12.90%
Unlock

Net Margin

2025 4.68% 43.21%
2026
6.79% 45.04%
Unlock
2027
7.38% 8.69%
Unlock
2028
7.91% 7.18%
Unlock
2029
9.08% 14.79%
Unlock
2030
8.36% 7.93%
Unlock
2031
8.77% 4.90%
Unlock
2032
9.08% 3.53%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share HKD 0.10 0.16
42.86% 60.00%
P/E 41.80
EV/Sales 2.64

19 Analysts have issued a Alibaba Health Information Technology forecast for earnings per share. The average Alibaba Health Information Technology EPS is

HKD0.16
Unlock
. This is
60.00% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HKD0.19 90.00%
Unlock
, the lowest is
HKD0.11 10.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HKD0.10 42.86%
2026
HKD0.16 60.00%
Unlock
2027
HKD0.19 18.75%
Unlock
2028
HKD0.22 15.79%
Unlock
2029
HKD0.28 27.27%
Unlock
2030
HKD0.29 3.57%
Unlock
2031
HKD0.34 17.24%
Unlock
2032
HKD0.38 11.76%
Unlock

P/E ratio

Current 65.60 46.24%
2026
41.80 36.28%
Unlock
2027
34.81 16.72%
Unlock
2028
30.08 13.59%
Unlock
2029
23.69 21.24%
Unlock
2030
22.25 6.08%
Unlock
2031
19.38 12.90%
Unlock
2032
17.16 11.46%
Unlock

Based on analysts' sales estimates for 2026, the Alibaba Health Information Technology stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.94 116.18%
2026
2.64 10.12%
Unlock
2027
2.39 9.45%
Unlock
2028
2.22 7.43%
Unlock
2029
2.00 9.54%
Unlock
2030
1.73 13.58%
Unlock
2031
1.58 8.54%
Unlock
2032
1.45 8.36%
Unlock

P/S ratio

Current 3.20 86.81%
2026
2.88 10.10%
Unlock
2027
2.61 9.45%
Unlock
2028
2.41 7.43%
Unlock
2029
2.18 9.55%
Unlock
2030
1.89 13.58%
Unlock
2031
1.73 8.54%
Unlock
2032
1.58 8.36%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today